Marimed (MRMD) FCF Payout Ratio Growth (1y) (2018 - 2026)
Marimed (MRMD) FCF Payout Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 15.81% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -130.26% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.52 Bn | 1.16 Bn | 37.82% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | -6.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.71% |
| Dec 31, 2025 | 187.03% |
| Sep 30, 2025 | 109.26% |
| Jun 30, 2025 | -193.75% |
| Mar 31, 2025 | 119.83% |
| Dec 31, 2024 | 7.56% |
| Sep 30, 2024 | -346.26% |
| Jun 30, 2024 | 100.44% |
| Mar 31, 2024 | -3,652.79% |
| Dec 31, 2023 | -101.37% |
| Sep 30, 2023 | -55.29% |
| Jun 30, 2023 | -3,370.53% |
| Mar 31, 2023 | -133.63% |
| Dec 31, 2022 | 3,381.77% |
| Sep 30, 2022 | 38.25% |
| Jun 30, 2022 | -204.36% |
| Mar 31, 2022 | 83.33% |
| Dec 31, 2021 | 107.83% |
| Sep 30, 2021 | 125.82% |
| Jun 30, 2021 | -91.98% |